Exact Sciences, GenMark Diagnostics Stand Out in June GWDN Index as Brexit Fears Push Stocks Down | GenomeWeb

NEW YORK (GenomeWeb) – The GenomeWeb Index fell 0.5 percent in June as stocks and indices fell on fears of what will happen now that the UK has voted to leave the European Union.

The Index underperformed the Dow Jones Industrial Average, which was able to rally after significant losses in the last week of June to gain 0.8 percent overall during the month. However, the GWDN Index outperformed both the Nasdaq and the Nasdaq Biotechnology Index, which lost 2 percent and nearly 8 percent in June, respectively.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.